ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT:BTX) today reported that it has received authorization to begin its pivotal human clinical trial of Renevia™ in Europe. In the trial, Renevia will be used in combination with the patient’s own fat-derived cells and injected into portions of the patient’s face where there has been a loss of […]
OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced certain executive management changes. Mark Colonnese, the Chief Financial Officer and Executive Vice President of Transgenomic, resigned from the Company effective October 30, 2014. Paul […]
MILFORD, Mass.– SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced seven new AccuSpan™ molecular linearity panels for the detection of Adenovirus (ADV), Varicella Zoster Virus (VZV), JC Virus (JCV), Herpes Simplex Virus 1 (HSV1), Herpes Simplex Virus 2 (HSV2), […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced it has completed its acquisition of Rocklin, California based Cell Marque Corporation, an industry-leading provider of in vitro diagnostic (IVD) antibody reagents and kits. The Company expects this acquisition to be neutral to mildly accretive to earnings per share […]
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics™, which dramatically improves the identification of biomarkers in tumour tissue. Definiens’ proprietary Cognition Network Technology® was developed by […]
LITTLE ROCK, Ark.– Vivione Biosciences Inc. (“Vivione”) (TSX:VBI), through its wholly owned subsidiary, Vivione Biosciences, LLC, is pleased to announce that it will begin a clinical pilot evaluation of its RAPID-B platform at the prestigious Cleveland Clinic Department of Pathology. “We’re excited about the opportunity to work with Dr. Gary Procop on the clinical pilot […]
ALAMEDA, Calif. & JERUSALEM — BioTime, Inc. (NYSE MKT:BTX) and Cell Cure Neurosciences Ltd. (Cell Cure) today announced that the U.S. Food and Drug Administration (FDA) has cleared Cell Cure’s Investigational New Drug (IND) application to initiate a Phase I/IIa clinical trial of OpRegen® in patients with the severe form of age-related macular degeneration (AMD) […]
OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced a research agreement with the University of Melbourne to conduct additional clinical validation studies of its Multiplexed ICE COLD-PCRTM (MX-ICP) technology. MX-ICP is a high […]
HTG Molecular Diagnostics, Inc. (HTG), a provider of instruments and reagents for molecular profiling applications, today announced that it entered into an agreement with Illumina, Inc. (NASDAQ:ILMN), under which HTG will have the right to develop certain in-vitro diagnostic (IVD) test kits that utilize Illumina sequencing technology. “We believe pairing the HTG EdgeSeq chemistry and […]
Hilden, Germany, and Tokyo, Japan -— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a master collaboration agreement with Astellas Pharma Inc., an R&D-driven global pharmaceutical company headquartered in Japan, to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of the agreement is […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
